PF-06747143 and its Fab and F(ab’)2 forms block CXCL12-induced calcium flux. The calcium flux assay was performed in human T cell leukemia Jurkat cells incubated with PF-06747143 full-length (FL), PF-06747143-Fab, PF-06747143 F(ab’)2, or isotype control IgG1 antibody in presence of CXCL12 at 8 nM. For adequate comparison between the different forms of the antibody, their concentrations were adjusted relative to their antigen-binding site numbers. Experiment was performed in quadruplicates. The mean intracellular calcium concentration is shown in relative fluorescence units (RFU). Bars denote standard error of the mean (SEM). (PDF 389 kb
Increased LC3B fluorescence signal in B1V following CQ treatment. Panc03.27S–Nt and Panc03.27R–B1V c...
Figure S1. Granulocyte-colony stimulating factor and DMSO vehicle do not induce proliferation of Ewi...
Figure S4. Effects of 17β-estradiol (E2) ± HDAC inhibitor treatments on PMCA4 protein expression in ...
CXCR4 expression profiling in different cell lines. CXCR4 expression was performed using the 2B11 CX...
Quantification of immunostaining of CXCR4 and CXCL12 protein by digital image analysis. (A) The numb...
Figure S1. Two pathways control Ca2+ signaling in B cells from patients with chronic lymphocytic leu...
Table S1. B cell receptors (BCR) and co-receptors analysis in B-CLL cells (n = 30) according to the ...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Western blot analysis of CXCR4 protein expression with N- and C-terminal directed antibodies. Wester...
Figure S3. Ca2+ signal measurement in E2-treated GCaMP2-MCF-7 cells. Cells were cultured in E2-free ...
Figure S1. Ibrutinib inhibits calcium flux of splenic B cells in vivo. Maximum ratio of bound/free i...
β-arrestin 2 pool titrations. HEK293T cells were cotransfected with fixed amounts of CXCR4-ElucC and...
Gating strategy for flow cytometric analysis. Gating strategy for flow cytometric analysis used to i...
Table S1. Plerixafor treatment changes receptor tyrosine kinase phosphorylation patterns in CXCR4-hi...
Hu5c8, aglycosyl hu5c8 and CDP7657 are all inactive in the absence of sCD40L, as was sCD40L alone. I...
Increased LC3B fluorescence signal in B1V following CQ treatment. Panc03.27S–Nt and Panc03.27R–B1V c...
Figure S1. Granulocyte-colony stimulating factor and DMSO vehicle do not induce proliferation of Ewi...
Figure S4. Effects of 17β-estradiol (E2) ± HDAC inhibitor treatments on PMCA4 protein expression in ...
CXCR4 expression profiling in different cell lines. CXCR4 expression was performed using the 2B11 CX...
Quantification of immunostaining of CXCR4 and CXCL12 protein by digital image analysis. (A) The numb...
Figure S1. Two pathways control Ca2+ signaling in B cells from patients with chronic lymphocytic leu...
Table S1. B cell receptors (BCR) and co-receptors analysis in B-CLL cells (n = 30) according to the ...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Western blot analysis of CXCR4 protein expression with N- and C-terminal directed antibodies. Wester...
Figure S3. Ca2+ signal measurement in E2-treated GCaMP2-MCF-7 cells. Cells were cultured in E2-free ...
Figure S1. Ibrutinib inhibits calcium flux of splenic B cells in vivo. Maximum ratio of bound/free i...
β-arrestin 2 pool titrations. HEK293T cells were cotransfected with fixed amounts of CXCR4-ElucC and...
Gating strategy for flow cytometric analysis. Gating strategy for flow cytometric analysis used to i...
Table S1. Plerixafor treatment changes receptor tyrosine kinase phosphorylation patterns in CXCR4-hi...
Hu5c8, aglycosyl hu5c8 and CDP7657 are all inactive in the absence of sCD40L, as was sCD40L alone. I...
Increased LC3B fluorescence signal in B1V following CQ treatment. Panc03.27S–Nt and Panc03.27R–B1V c...
Figure S1. Granulocyte-colony stimulating factor and DMSO vehicle do not induce proliferation of Ewi...
Figure S4. Effects of 17β-estradiol (E2) ± HDAC inhibitor treatments on PMCA4 protein expression in ...